Market revenue in 2023 | USD 3.1 million |
Market revenue in 2030 | USD 6.9 million |
Growth rate | 12.3% (CAGR from 2023 to 2030) |
Largest segment | Product |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Product, Services |
Key market players worldwide | Thermo Fisher Scientific Inc, Illumina Inc, Qiagen NV, Abcam PLC, Takara Bio Inc, Revvity Inc, Maravai LifeSciences Holdings Inc Ordinary Shares - Class A, HTG Molecular Diagnostics Inc, Meridian Bioscience, New England Biolabs, Norgen Biotek, System Biosciences, Amoy Diagnostics, EntroGen |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mirna sequencing and assay market will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 80.65% in 2023. Horizon Databook has segmented the Mexico mirna sequencing and assay market based on product, services covering the revenue growth of each sub-segment from 2018 to 2030.
Mexico miRNA sequencing and assay market has high-growth potential in the Latin American region owing to increasing initiatives undertaken by private and non-private organizations. For instance, Consejo Nacional de Ciencia y Tecnología (the National Council of Science and Technology) is a government agency that promotes and sponsors development of scientific research and technologies.
Mexico is one of the preferred countries for medical tourism along with India, China, and Thailand. The market for miRNA sequencing is fueled by growing miRNA applications and demand for innovative therapies, which is boosted by growing medical tourism in the country. In addition, ongoing research studies to develop novel applications of miRNA aid growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico mirna sequencing and assay market , including forecasts for subscribers. This country databook contains high-level insights into Mexico mirna sequencing and assay market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account